Skip to main content

Table 4 Differences in patient characteristics and self-reported outcome between patients with high and low pain catastrophizing score

From: The association between pain catastrophizing, physical function and pain in a cohort of patients undergoing knee arthroplasty

 

All patients

TKA

UKA

PCS < 11

PCS > 21

P-value

PCS < 11

PCS > 21

PCS < 11

PCS > 21

n = 205

n = 207

n = 138

n = 165

n = 67

n = 42

Female (%)

106 (51.7)

112 (54.1)

0.63

73 (52.9)

92 (55.8)

33 (49.3)

20 (47.6)

Age years (SD)

67.7 (9.2)

66.7 (10.0)

0.37

68.1 (9.0)

67.0 (9.9)

66.7 (9.5)

65.9 (10.4)

BMI kg/m2 (SD)

28.2 (4.3)

29.7 (4.4)

< 0.001

28.0 (4.2)

29.8 (4.5)

28.7 (4.4)

29.3 (4.1)

Alcohol > 24 g/Day (%)

11 (5.6)

9 (4.6)

0.70

7 (5.2)

8 (5.1)

4 (6.5)

1 (2.3)

Smoking (%)

25 (12.6)

33 (16.9)

0.22

21 (15.4)

27 (17.2)

4 (6.5)

6 (15.8)

Co-morbiditya (%)

139 (67.8)

153 (73.9)

0.24

100 (72.5)

124 (75.2)

39 (58.2)

29 (69.0)

Walking aid (%)

24 (12.1)

38 (19.5)

0.03

21 (15.4)

30 (19.1)

3 (4.8)

8 (21.1)

Living alone (%)

53 (26.8)

42 (21.5)

0.23

37 (27.2)

33 (21.7)

16 (25.8)

9 (23.7)

Operated bilateralb (%)

20 (9.7)

16 (7.7)

0.52

13 (9.4)

13 (7.9)

7 (10.5)

7 (7.1)

Outcome

Preoperatively

 OKS (IQR) (n = 412)

29 (9)

21 (8)

< 0.001

28 (10)

21 (8)

31 (8)

22 (8)

 Pain (%) (n = 412)

127 (61.2)

187 (90.3)

< 0.001

89 (64.5)

152 (92.1)

38 (56.7)

35 (83.3)

 SF-36 (PF) (IQR) (n = 404)

50 (35)

35 (25)

< 0.001

50 (35)

35 (25)

57.5 (30)

35 (20)

 EQ 5D (IQR) (n = 376)

0.72 (0.08)

0.66 (0.33)

< 0.001

0.72 (0.05)

0.66 (0.33)

0.77 (0.10)

0.59 (0.40)

4 months

 OKS (IQR) (n = 336)

39 (10)

36 (12)

0.001

37 (11)

35 (11)

41 (8)

37 (12)

 Pain (%) (n = 412)

32 (17.7)

56 (33.9)

0.001

25 (20.8)

47 (36.2)

7 (11.5)

9 (25.7)

 SF-36 (PF) (IQR) (n = 346)

80 (25)

75 (30)

0.004

75 (30)

75 (30)

85 (15)

80 (30)

 EQ 5D (IQR) (n = 331)

0.82 (0.23)

0.82 (0.28)

0.023

0.82 (0.28)

0.82 (0.28)

0.84 (0.18)

0.82 (0.23)

12 months

 OKS (IQR) (n = 412)

42 (10)

38 (13)

< 0.001

41 (11)

37 (14)

44 (8)

41 (8)

 Pain (%) (n = 412)

21 (10.2)

49 (23.7)

< 0.001

16 (11.6)

42 (25.5)

5 (7.5)

7 (16.7)

 SF-36 (PF) (IQR) (n = 401)

85 (25)

75 (30)

0.001

80 (30)

75 (32.5)

85 (20)

80 (20)

 EQ 5D (IQR) (n = 397)

0.84 (0.22)

0.82 (0.28)

0.002

0.84 (0.22)

0.82 (0.28)

1 (0.28)

0.82 (0.23)

  1. Parentheses are percentage unless otherwise specified. Pain is dichotomized from OKS q1 in “no pain” (none/very mild/mild) and “pain” (moderate/severe). P-value for outcome is measured from multivariate repeated measurements ANOVA for OKS and SF36 (PF) and chi square test and Wilcoxon signed-rank test for pain and EQ.5D
  2. acardiac disease, pulmonary disease, high blood pressure, hypercholesterolaemia, diabetes, psychiatric disorder, previous stroke, and previous venous thromboembolic event
  3. bPatients having two knee arthroplasties within 12 months